Source: Outsourcing-Pharma

Bendalis GmbH: Inceptua and Bendalis partner on 'Brexit-safe' clinical trial supply service

Inceptua Group and Bendalis join forces to supply generic cancer drugs for use in clinical trials.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
CEO Avatar

CEO

Christian Parvany

CEO Approval Rating

90/100